US and Europe Private Company Trends: Strong performance despite global headwinds – executive summary
ICG establishes strategic partnership with Hanwha Energy Corporation to accelerate energy transition investment in Japan
Life Sciences Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by ICG 6 January 2023
Life Sciences ICG’s Sale & Leaseback Fund agrees sale & leaseback of Life Science Research and Development facility in the Netherlands 25 March 2021
Back